Immunoglobulins: Benefits and risks from the patient's point of view - 21/09/17
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Summary |
Patients have to be informed about the risks and benefits of medicinal products derived from human plasma. No study has examined the patient's perspective yet. Our objective was to assess perceived benefits and risks of immunoglobulins administration from the patient's point of view. Thirty-four patients receiving subcutaneous or intravenous immunoglobulins for chronic disorders at a single university hospital were asked to complete a survey. Although the level of comfort was high, the results revealed variable and incomplete knowledge, in particular about the nature of the treatment. Greater efforts should be made by health professionals to provide information to patients about plasma-derived medicinal products.
Le texte complet de cet article est disponible en PDF.Keywords : Immunoglobulins, Informed consent, Patient education, Patient satisfaction
Plan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?